Amgen Inc. buy phonebroker
Start price
28.08.17
/
50%
€154.96
Target price
01.09.17
€161.46
Performance (%)
4.55%
End price
01.09.17
€162.02
Summary
This prediction ended on 01.09.17 with a price of €162.02. The BUY prediction by phonebroker finished with a performance of 4.55%. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 2.368% | 2.368% | 46.511% | 52.469% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 28.08.2017 dem Buy-Gesamtsentiment mit dem Kursziel 179.0$ zu.
(Zielkurs erreicht)


